Investors — not yet on record
No investors in Acrivon Therapeutics are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Acrivon Therapeutics
Create free account
No card required